Stanley M Marks Blood Cancer Research Fund
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | — | — |
| 2018 | 364,793 | 348,633 | 16,160 | 0.6 | 0% |
| 2019 | 506,625 | 495,477 | 11,148 | 0.7 | 0% |
| 2020 | 386,451 | 397,715 | −11,264 | 0.5 | 0% |
| 2021 | 685,456 | 671,675 | 13,781 | 0.5 | 0% |
| 2022 | 661,800 | 637,448 | 24,352 | 1.0 | 0% |
| 2023 | 859,096 | 865,849 | −6,753 | 0.7 | 0% |
In its most recent public year (2023), this organization spent $6,753 more than it brought in. Its reserves stood at about 0.7 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Stanley M Marks Blood Cancer Research Fund's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works